CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid in Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2022	$ 364,285	$ (7,818)	$ 199	$ 201,494	$ 171,613	$ (7,818)	$ (9,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	6,457				6,457
Other comprehensive loss	860						860
Common shares issued for employee stock purchase plan	87			87
Stock-based compensation	155			155
Cash dividends declared	(2,388)				(2,388)
Ending balance at Mar. 31, 2023	361,638		199	201,736	167,864		(8,161)
Beginning balance at Dec. 31, 2022	364,285	$ (7,818)	199	201,494	171,613	$ (7,818)	(9,021)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	738
Other comprehensive loss	(1,088)
Ending balance at Sep. 30, 2023	501,578		331	355,575	155,781		(10,109)
Beginning balance at Mar. 31, 2023	361,638		199	201,736	167,864		(8,161)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	4,018				4,018
Other comprehensive loss	(400)						(400)
Common shares issued for employee stock purchase plan	102			102
Stock-based compensation	170			170
Cash dividends declared	(2,388)				(2,388)
Ending balance at Jun. 30, 2023	363,140		$ 199	202,008	169,494		(8,561)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(9,737)				(9,737)
Other comprehensive loss	(1,548)						(1,548)
Common shares issued for employee stock purchase plan	83			83
Stock-based compensation	529			529
Cash dividends declared	(3,976)				(3,976)
TCFC acquisition (in shares)			132,000
TCFC acquisition	153,087			152,955
Ending balance at Sep. 30, 2023	501,578		$ 331	355,575	155,781		(10,109)
Beginning balance at Dec. 31, 2023	511,135		332	356,007	162,290		(7,494)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	8,184				8,184
Other comprehensive loss	(564)						(564)
Common shares issued for employee stock purchase plan	103			103
Stock-based compensation	354			354
Cash dividends declared	(3,984)				(3,984)
Ending balance at Mar. 31, 2024	515,228		332	356,464	166,490		(8,058)
Beginning balance at Dec. 31, 2023	511,135		332	356,007	162,290		(7,494)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	30,607
Other comprehensive loss	1,968
Ending balance at Sep. 30, 2024	533,271		333	357,580	180,884		(5,526)
Beginning balance at Mar. 31, 2024	515,228		$ 332	356,464	166,490		(8,058)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	11,234				11,234
Other comprehensive loss	(202)						(202)
Common shares issued for employee stock purchase plan (in shares)			1,000
Common shares issued for employee stock purchase plan	121			120
Stock-based compensation	410			410
Cash dividends declared	(4,008)				(4,008)
Ending balance at Jun. 30, 2024	522,783		$ 333	356,994	173,716		(8,260)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	11,189				11,189
Other comprehensive loss	2,734						2,734
Common shares issued for employee stock purchase plan	98			98
Stock-based compensation	488			488
Cash dividends declared	(4,021)				(4,021)
Ending balance at Sep. 30, 2024	$ 533,271		$ 333	$ 357,580	$ 180,884		$ (5,526)